Forbius announces the first patient dosed in a Phase 1 trial of AVID200
World | News | 0 Comment | 09 Jan, 2019
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...Read more
Medidata appoints Sastry Chilukuri as Executive VP of digital and AI solutions
World | News | 0 Comment | 09 Jan, 2019
Medidata has announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its sen...Read more
Leica Biosystems gets US patent for RTF Technology
World | News | 0 Comment | 09 Jan, 2019
Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has grante...Read more
Generex Biotechnology acquires Regentys Corporation
World | News | 0 Comment | 08 Jan, 2019
Generex Biotechnology Corporation has announced that the company has completed the acquisition of 51% of Regentys Corpor...Read more
MYnd Analytics, Emmaus Life Sciences announce merger and spin-off transaction
World | News | 0 Comment | 08 Jan, 2019
MYnd Analytics, a predictive analytics company aimed at improving the delivery of mental health services through the com...Read more
Lupin’s NaMuscla receives EC Approval
World | News | 0 Comment | 08 Jan, 2019
Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...Read more
Stemedica reveals positive results for Ischemic stroke treatment
World | News | 0 Comment | 08 Jan, 2019
Stemedica Cell Technologies announced positive results from its Phase I/IIa clinical study for the treatment of ischemic...Read more
Eli Lilly acquires Loxo Oncology for $8B
World | News | 0 Comment | 07 Jan, 2019
Eli Lilly and Loxo Oncology, have announced a definitive agreement for Lilly to acquire Loxo Oncol...Read more
MIT LFE with Informa Pharma Intelligence launches project ALPHA
World | News | 0 Comment | 07 Jan, 2019
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced Project ALPHA (Analytics fo...Read more
Ribon Therapeutics raises $65M
World | News | 0 Comment | 07 Jan, 2019
Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...Read more
Green Leaf Medical raises $20M for expansion
World | News | 0 Comment | 07 Jan, 2019
Green Leaf Medical, LLC, a MSO (Multi-State Operator) of medical cannabis facilities in the Northeast United S...Read more
MD Anderson Cancer Centre, 4D pharma collaborate to evaluate live biotherapeutics in solid tumors
World | News | 0 Comment | 07 Jan, 2019
The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate...Read more
Ironwood Pharma appoints Michael Shetzline as CMO
World | News | 0 Comment | 07 Jan, 2019
Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...Read more
Bristol-Myers Squibb to acquire Celgene
World | News | 0 Comment | 04 Jan, 2019
Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...Read more
J&J, Locus Bioscience collaborate to develop CRISPR-Cas3 bacteriophage therapeutics
World | News | 0 Comment | 04 Jan, 2019
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...Read more
Generex Biotechnology partners with Olaregen Therapeutix
World | News | 0 Comment | 04 Jan, 2019
Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...Read more
AstraZeneca’s Bevespi Aerosphere approved in the EU
World | News | 0 Comment | 03 Jan, 2019
AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...Read more
ImaginAb Announces Strengthening of Board and Executive Leadership Team
World | News | 0 Comment | 03 Jan, 2019
ImaginAb, a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...Read more